Skip to main content
logo
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
28.75
-0.64 (-2.18%)
At close: Aug 26, 2026, 4:00 PM EDT
28.90
+0.15 (0.52%)
Pre-market: Aug 27, 2026, 7:46 AM EDT

Immunome Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,2652,37066345727157
Market Cap Growth
278.16%257.53%44.98%1605.70%-82.91%53.68%
Enterprise Value
2,7502,101425367-0101
Last Close Price
28.7521.4810.6210.702.2112.96

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-341.4473.3232.62--
PB Ratio
6.213.743.663.811.613.26
P/TBV Ratio
6.223.743.663.811.613.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-302.7447.0626.18--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.030.010.02-
Net Debt / Equity Ratio
-0.98-1.02-1.17-1.14-1.20-1.02
Net Debt / EBITDA Ratio
2.003.071.404.830.552.01
Net Debt / FCF Ratio
2.353.241.8016.250.692.69
Asset Turnover
-0.020.050.16--
Quick Ratio
14.6414.534.006.332.895.50
Current Ratio
15.0814.694.086.633.095.82
Return on Equity (ROE)
-64.03%-52.09%-194.63%-156.45%-113.81%-55.20%
Return on Assets (ROA)
-37.79%-28.98%-49.34%-20.81%-56.27%-30.75%
Return on Capital Employed (ROCE)
-49.20%-33.50%-82.50%-22.70%-220.80%-52.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.79%-8.96%-44.20%-23.36%-137.65%-15.76%
FCF Yield
-6.71%-8.46%-17.80%-1.84%-107.96%-11.67%
Buyback Yield / Dilution
-41.38%-48.96%-195.51%-63.64%-5.10%-240.41%
SEC Filings: 10-K · 10-Q